The stock has a 36-month beta value of 1.02. Opinions on the stock are mixed, with 9 analysts rating it as a “buy,” 4 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for EVH is 114.29M, and at present, short sellers hold a 13.32% of that float. On July 02, 2025, the average trading volume of EVH was 2.56M shares.
EVH) stock’s latest price update
Evolent Health Inc (NYSE: EVH)’s stock price has plunge by 3.29relation to previous closing price of 11.26. Nevertheless, the company has seen a 9.51% surge in its stock price over the last five trading sessions. zacks.com reported 2025-06-23 that Evolent Health (EVH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
EVH’s Market Performance
Evolent Health Inc (EVH) has seen a 9.51% rise in stock performance for the week, with a 56.11% gain in the past month and a 22.81% surge in the past quarter. The volatility ratio for the week is 4.24%, and the volatility levels for the past 30 days are at 5.78% for EVH. The simple moving average for the past 20 days is 24.26% for EVH’s stock, with a -13.84% simple moving average for the past 200 days.
Analysts’ Opinion of EVH
Many brokerage firms have already submitted their reports for EVH stocks, with Needham repeating the rating for EVH by listing it as a “Buy.” The predicted price for EVH in the upcoming period, according to Needham is $15 based on the research report published on January 10, 2025 of the current year 2025.
BTIG Research, on the other hand, stated in their research note that they expect to see EVH reach a price target of $29, previously predicting the price at $36. The rating they have provided for EVH stocks is “Buy” according to the report published on December 03rd, 2024.
Stephens gave a rating of “Equal-Weight” to EVH, setting the target price at $16 in the report published on November 08th of the previous year.
EVH Trading at 27.77% from the 50-Day Moving Average
After a stumble in the market that brought EVH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.42% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EVH starting from Holder Diane, who purchase 2,735 shares at the price of $9.33 back on Mar 06 ’25. After this action, Holder Diane now owns 70,584 shares of Evolent Health Inc, valued at $25,518 using the latest closing price.
McCarthy Daniel Joseph, the PRESIDENT of Evolent Health Inc, purchase 11,040 shares at $9.01 during a trade that took place back on Mar 06 ’25, which means that McCarthy Daniel Joseph is holding 389,004 shares at $99,470 based on the most recent closing price.
Stock Fundamentals for EVH
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.14 for the gross margin
The net margin for Evolent Health Inc stands at -0.05. The total capital return value is set at -0.01. Equity return is now at value -10.99, with -4.11 for asset returns.
Based on Evolent Health Inc (EVH), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at 0.02. The debt to equity ratio resting at 0.93. The interest coverage ratio of the stock is -0.93.
Currently, EBITDA for the company is 84.85 million with net debt to EBITDA at 16.86. When we switch over and look at the enterprise to sales, we see a ratio of 0.83. The receivables turnover for the company is 5.57for trailing twelve months and the total asset turnover is 0.9. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.98.
Conclusion
To sum up, Evolent Health Inc (EVH) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
